Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Johnson & Johnson’s DePuy Orthopaedics subsidiary lands a supplemental pre-market approval from the FDA for use of its Trumatch Personalized Solutions system with its already-approved Sigma RP knee implant.
Long-time Mela Sciences CEO Joseph Gulfo tenders his resignation after 9 years at the helm, with board member Robert Coradini named to take the helm on an interim basis.
A study finds that doctors might avoid treating the sickest heart patients over concerns about new transparency and hospital labeling rules.